Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2016

01-04-2016 | IM - REVIEW

Prevention programs for chronic kidney disease in low-income countries

Authors: Norberto Perico, Giuseppe Remuzzi

Published in: Internal and Emergency Medicine | Issue 3/2016

Login to get access

Abstract

Chronic kidney disease (CKD) is an important determinant of the poor health outcome for major noncommunicable diseases that are the leading cause of death worldwide. Early recognition with screening programs of CKD and co-morbid conditions, like hypertension, diabetes, or toxic environments, can potentially slow progression to renal failure, improve quality of life and reduce healthcare cost. Effective multimodal tools are available to prevent CKD by managing its risk factors, and to slow or even halt disease progression to end-stage renal failure (ESRF). They can be adapted even to poor-resource settings of low- and middle-income countries for individual at high risk of CKD. CKD is also linked to acute kidney injury (AKI), that in poorest part of Africa, Asia and Latin America is preventable, treatable and often reversible, if managed adequately and in timely manner as proposed by the program "AKI 0by25" launched by the international Society of Nephrology in 2013. In addition to saving lives, prevention programs will create major heath gains, eventually reducing the current health inequity that arises from unaffordable or unobtainable renal replacement therapies in many part of the developing world if ESRF is not prevented.
Literature
1.
go back to reference GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171CrossRefPubMedCentral GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171CrossRefPubMedCentral
2.
go back to reference WHO (2002) The world health report 2002. World Health Organization, Geneva WHO (2002) The world health report 2002. World Health Organization, Geneva
3.
go back to reference WHO (2005) Preventing chronic disease: a vital investment. World Health Organization, Geneva WHO (2005) Preventing chronic disease: a vital investment. World Health Organization, Geneva
4.
go back to reference Murray C, Lopez A (1996) The global burden of disease. Harvard School of Public Health, Boston Murray C, Lopez A (1996) The global burden of disease. Harvard School of Public Health, Boston
5.
go back to reference International Diabetes Federation (2015) International Diabetes Federation, Diabetes Atlas, 7th edn. International Diabetes Federation, Brussels International Diabetes Federation (2015) International Diabetes Federation, Diabetes Atlas, 7th edn. International Diabetes Federation, Brussels
6.
go back to reference King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed
7.
go back to reference Levitt NS (2008) Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94:1376–1382CrossRefPubMed Levitt NS (2008) Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94:1376–1382CrossRefPubMed
8.
go back to reference International Diabetes Federation (2009) International Diabetes Federation, Diabetes Atlas, 4th edn. International Diabetes Federation, Brussels International Diabetes Federation (2009) International Diabetes Federation, Diabetes Atlas, 4th edn. International Diabetes Federation, Brussels
9.
go back to reference Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800 CrossRefPubMedCentral Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800 CrossRefPubMedCentral
10.
go back to reference Couser WG, Remuzzi G, Mendis S, Tonelli M (2011) The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80:1258–1270CrossRefPubMed Couser WG, Remuzzi G, Mendis S, Tonelli M (2011) The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80:1258–1270CrossRefPubMed
11.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128CrossRefPubMed
12.
go back to reference Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M (2015) Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol 26:2621–2633CrossRefPubMed Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M (2015) Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol 26:2621–2633CrossRefPubMed
13.
go back to reference Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:1975–1982CrossRefPubMed Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:1975–1982CrossRefPubMed
14.
go back to reference Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382:260–272CrossRefPubMed Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382:260–272CrossRefPubMed
15.
go back to reference Remuzzi G, Perico N (2014) International Society of Nephrology’s perspective on the emergence of chronic kidney diseases of unknown/undetermined etiology. MEDICC Rev 16:75–76PubMed Remuzzi G, Perico N (2014) International Society of Nephrology’s perspective on the emergence of chronic kidney diseases of unknown/undetermined etiology. MEDICC Rev 16:75–76PubMed
16.
go back to reference Vassalotti JA, Li S, McCullough PA, Bakris GL (2010) Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin Nephrol 30:66–73CrossRefPubMed Vassalotti JA, Li S, McCullough PA, Bakris GL (2010) Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin Nephrol 30:66–73CrossRefPubMed
17.
go back to reference Remuzzi G, Ruggenenti P, Perico N (2002) Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 136:604–615CrossRefPubMed Remuzzi G, Ruggenenti P, Perico N (2002) Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 136:604–615CrossRefPubMed
18.
go back to reference Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remission, regression of chronic renal diseases. Lancet 357:1601–1608CrossRefPubMed Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remission, regression of chronic renal diseases. Lancet 357:1601–1608CrossRefPubMed
19.
go back to reference Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G (2008) Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 19:1213–1224CrossRefPubMedPubMedCentral Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G (2008) Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 19:1213–1224CrossRefPubMedPubMedCentral
20.
go back to reference Obrador GT, Garcia-Garcia G, Villa AR, Rubilar X, Olvera N, Ferreira E, Virgen M, Gutierrez-Padilla JA, Plascencia-Alonso M, Mendoza-Garcia M, Plascencia-Perez S (2010) Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int Suppl 116:S2–S8CrossRefPubMed Obrador GT, Garcia-Garcia G, Villa AR, Rubilar X, Olvera N, Ferreira E, Virgen M, Gutierrez-Padilla JA, Plascencia-Alonso M, Mendoza-Garcia M, Plascencia-Perez S (2010) Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int Suppl 116:S2–S8CrossRefPubMed
21.
go back to reference Luyckx VA, Brenner BM (2015) Birth weight, malnutrition and kidney-associated outcomes—a global concern. Nat Rev Nephrol 11:135–149CrossRefPubMed Luyckx VA, Brenner BM (2015) Birth weight, malnutrition and kidney-associated outcomes—a global concern. Nat Rev Nephrol 11:135–149CrossRefPubMed
22.
go back to reference Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U (2014) The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2:e174–e181CrossRefPubMed Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U (2014) The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2:e174–e181CrossRefPubMed
24.
go back to reference Cravedi P, Sharma SK, Bravo RF, Islam N, Tchokhonelidze I, Ghimire M, Pahari B, Thapa S, Basnet A, Tataradze A, Tinatin D, Beglarishvili L, Fwu CW, Kopp JB, Eggers P, Ene-Iordache B, Carminati S, Perna A, Chianca A, Couser WG, Remuzzi G, Perico N (2012) Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA. BMJ Open 2(5):e001357. doi:10.1136/bmjopen-2012-001357 CrossRefPubMedCentral Cravedi P, Sharma SK, Bravo RF, Islam N, Tchokhonelidze I, Ghimire M, Pahari B, Thapa S, Basnet A, Tataradze A, Tinatin D, Beglarishvili L, Fwu CW, Kopp JB, Eggers P, Ene-Iordache B, Carminati S, Perna A, Chianca A, Couser WG, Remuzzi G, Perico N (2012) Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA. BMJ Open 2(5):e001357. doi:10.​1136/​bmjopen-2012-001357 CrossRefPubMedCentral
25.
go back to reference Bottomley MJ, Kalachik A, Mevada C, Brook MO, James T, Harden PN (2011) Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease. Nephron Clin Pract 117:c348–c352CrossRefPubMed Bottomley MJ, Kalachik A, Mevada C, Brook MO, James T, Harden PN (2011) Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease. Nephron Clin Pract 117:c348–c352CrossRefPubMed
26.
go back to reference Chen N, Hsu CC, Yamagata K, Langham R (2010) Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia. Nephrol (Carlton) 15(Suppl 2):31–36CrossRef Chen N, Hsu CC, Yamagata K, Langham R (2010) Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia. Nephrol (Carlton) 15(Suppl 2):31–36CrossRef
27.
go back to reference Sharma SK, Ghimire A, Carminati S, Remuzzi G, Perico N (2014) Management of chronic kidney disease and its risk factors in eastern Nepal. Lancet Glob Health 2:e506–e507CrossRefPubMed Sharma SK, Ghimire A, Carminati S, Remuzzi G, Perico N (2014) Management of chronic kidney disease and its risk factors in eastern Nepal. Lancet Glob Health 2:e506–e507CrossRefPubMed
29.
go back to reference Remuzzi G, Horton R (2013) Acute renal failure: an unacceptable death sentence globally. Lancet 382:2041–2042CrossRefPubMed Remuzzi G, Horton R (2013) Acute renal failure: an unacceptable death sentence globally. Lancet 382:2041–2042CrossRefPubMed
30.
go back to reference Mehta RL, Cerda J, Burdmann EA, Tonelli M, Garcia-Garcia G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385:2616–2643CrossRefPubMed Mehta RL, Cerda J, Burdmann EA, Tonelli M, Garcia-Garcia G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385:2616–2643CrossRefPubMed
Metadata
Title
Prevention programs for chronic kidney disease in low-income countries
Authors
Norberto Perico
Giuseppe Remuzzi
Publication date
01-04-2016
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 3/2016
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-016-1425-7

Other articles of this Issue 3/2016

Internal and Emergency Medicine 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.